Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587808 · ClinicalTrials.gov registry record
Mechanisms in Heart Failure With Normal EF
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 14
- Enrollment target
NCT00587808: Completed study, sponsored by Mayo Clinic.
NCT00587808 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587808 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The guiding hypotheses are that (1) mechanisms in addition to diastolic dysfunction, while normal at rest, are compromised with stress, leading to symptoms of HF, and (2) that an increased proportion of the increase in LV diastolic pressures seen in HFpEF is mediated via exaggerated pericardial/right heart-LV coupling (restraint).
Interventions
- PROCEDURE RHC with VO2 consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587808
The ClinicalTrials.gov registry entry for NCT00587808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RHC with VO2 consumption is the first listed.
NCT00587808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587808 about?
NCT00587808 is a clinical study titled "Mechanisms in Heart Failure With Normal EF". The guiding hypotheses are that (1) mechanisms in addition to diastolic dysfunction, while normal at rest, are compromised with stress, leading to symptoms of HF, and (2) that an increased proportion of the increase in LV diastolic pressures seen in HFpEF is mediated via exaggerated pericardial/righ...
What is the current status of trial NCT00587808?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2007-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00587808?
The interventions under investigation include: RHC with VO2 consumption (PROCEDURE).
Who is sponsoring clinical trial NCT00587808?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.